Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.42
+0.21 (0.67%)
At close: Jun 8, 2026, 4:00 PM EDT
32.39
-0.02 (-0.08%)
After-hours: Jun 8, 2026, 4:10 PM EDT

HRMY Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $44.36. The average 1-year stock price forecast is 36.85% higher than the current stock price, while the lowest is $28 (-13.62%) and the highest is $85 (+162.22%).

Price Target: $44.36 (+36.85%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$28$44.36$43$85
Change-13.62%+36.85%+32.65%+162.22%

Analyst Ratings

The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Apr '26May '26
Strong Buy777444
Buy222222
Hold111444
Sell111111
Strong Sell000000
Total111111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$55
BuyReiterates$55+69.67%May 22, 2026
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$50
BuyReiterates$50+54.25%May 11, 2026
Truist Financial
Truist Financial
Hold
Maintains
$25$29
HoldMaintains$25$29-10.54%May 8, 2026
Needham
Needham
Buy
Reiterates
$45
BuyReiterates$45+38.82%May 7, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$62$72
BuyMaintains$62$72+122.12%Apr 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.01B
from 868.45M
Increased by 16.44%
Revenue Next Year
1.15B
from 1.01B
Increased by 13.63%
EPS This Year
4.39
from 3.60
Increased by 22.03%
EPS Next Year
5.58
from 4.39
Increased by 27.05%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
305.44M437.86M582.02M714.73M868.45M1.01B
Revenue Growth
91.21%43.35%32.93%22.80%21.51%16.44%
Gross Profit
249.92M354.37M460.79M557.92M670.11M780.05M
Gross Margin
81.82%80.93%79.17%78.06%77.16%77.14%
Operating Income
87.53M120.19M192.03M190.83M208.47M266.15M
Net Income
34.60M181.47M128.85M145.49M158.69M211.58M
EPS
----3.604.39
EPS Growth
-----10.89%22.03%
Forward PE
25.2723.0111.1411.8210.057.38
Free Cash Flow
-123.53M72.97M214.83M143.91M211.46M191.30M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.0B
Avg1.0B
Low978.1M

Revenue Growth

Revenue Growth202620272028
High
18.0%
Avg
16.4%
Low
12.6%

EPS Forecast

EPS202620272028
High-
Avg4.39
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
22.0%
Low-